|
CTCFL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.494000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.965200E-01 |
| Normal-vs-Stage2 |
1.470190E-01 |
| Normal-vs-Stage3 |
3.982000E-02 |
| Normal-vs-Stage4 |
3.203800E-01 |
| Stage1-vs-Stage2 |
1.078440E-01 |
| Stage1-vs-Stage3 |
7.857600E-03 |
| Stage1-vs-Stage4 |
2.716400E-01 |
| Stage2-vs-Stage3 |
7.410000E-01 |
| Stage2-vs-Stage4 |
6.347200E-01 |
| Stage3-vs-Stage4 |
3.675800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.579000E-01 |
| Normal-vs-AfricanAmerican |
3.838400E-01 |
| Normal-vs-Asian |
9.877200E-01 |
| Caucasian-vs-AfricanAmerican |
1.672580E-01 |
| Caucasian-vs-Asian |
6.097600E-01 |
| AfricanAmerican-vs-Asian |
4.751800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.365000E-01 |
| Normal-vs-Female |
4.791000E-01 |
| Male-vs-Female |
7.957600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.861000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.405400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.539900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.794500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.756600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.439600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.173760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.522750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.048600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.904400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.973990E-02 |
| Classical-VS-Follicular |
2.358800E-03 |
| Classical-VS-Other |
4.658800E-01 |
| Classical-VS-Normal |
8.914600E-01 |
| Tall-VS-Follicular |
8.525000E-01 |
| Tall-VS-Other |
8.172000E-01 |
| Tall-VS-Normal |
9.055700E-02 |
| Follicular-VS-Other |
7.846000E-01 |
| Follicular-VS-Normal |
4.324100E-02 |
| Other-VS-Normal |
4.849800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.895580E-01 |
| Normal-vs-N1 |
6.390000E-01 |
| N0-vs-N1 |
4.844000E-01 |
|
|
